G. Torres

Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit

Miguel Martín, M. Cebollero, I. Márquez-Rodas, 2018, Journal of Genetic Counseling.

Cyclin Kinase Inhibitors in Breast Cancer: From Bench to Bedside

Miguel Martín, I. Márquez-Rodas, M. Lobo, 2014, Current Breast Cancer Reports.

Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer

J. García-Saenz, F. Moreno, Miguel Martín, 2017, Breast Cancer Research and Treatment.

FOLFOXIRI plus biologics in advanced colorectal cancer

A. Muñoz, G. Torres, P. García-Alfonso, 2019, Expert opinion on biological therapy.